9,691 Shares in The Clorox Company (NYSE:CLX) Purchased by B. Metzler seel. Sohn & Co. Holding AG

B. Metzler seel. Sohn & Co. Holding AG acquired a new position in The Clorox Company (NYSE:CLX) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 9,691 shares of the company’s stock, valued at approximately $1,579,000.

Several other large investors also recently added to or reduced their stakes in the company. Prospera Financial Services Inc increased its holdings in Clorox by 3.1% in the 3rd quarter. Prospera Financial Services Inc now owns 4,549 shares of the company’s stock worth $742,000 after acquiring an additional 135 shares during the last quarter. Caprock Group LLC increased its holdings in Clorox by 9.2% in the 3rd quarter. Caprock Group LLC now owns 2,841 shares of the company’s stock worth $463,000 after acquiring an additional 239 shares during the last quarter. Aviance Capital Partners LLC increased its holdings in Clorox by 2.7% in the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock worth $502,000 after acquiring an additional 80 shares during the last quarter. Baron Wealth Management LLC purchased a new stake in Clorox in the 3rd quarter worth about $250,000. Finally, Cassaday & Co Wealth Management LLC purchased a new position in Clorox during the 3rd quarter valued at about $231,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have weighed in on CLX shares. Evercore ISI reduced their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Deutsche Bank Aktiengesellschaft lifted their target price on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Citigroup lifted their target price on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and lifted their target price for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Finally, JPMorgan Chase & Co. lifted their target price on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. Five research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $155.00.

Insider Activity

In other news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. This represents a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.57% of the company’s stock.

Clorox Stock Up 0.1 %

Shares of CLX opened at $169.31 on Friday. The firm has a market cap of $20.96 billion, a P/E ratio of 58.99, a P/E/G ratio of 3.11 and a beta of 0.41. The stock has a 50 day simple moving average of $162.78 and a two-hundred day simple moving average of $148.43. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.35.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. Clorox’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.49 earnings per share. On average, analysts forecast that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.88%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 170.03%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.